Evidence map›Paper›PMID 24379662›Full record

ArticleInternational journal of nanomedicine2013

Intradermal air pouch leukocytosis as an in vivo test for nanoparticles.

Jennifer Vandooren, Nele Berghmans, Chris Dillen, Ilse Van Aelst, Isabelle Ronsse, Liron Limor Israel, Ina Rosenberger, Jörg Kreuter, Jean-Paul Lellouche, Shulamit Michaeli and 8 more

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Anti-Inflammatory Activity ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Evaluation of the in vitro and in vivo proinflammatory activities of gold (+) and gold (-) nanoparticles.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Article
  13. Article
  14. In vivo proinflammatory activity of generations 0-3 (G0-G3) polyamidoamine (PAMAM) nanoparticles.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2016
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Jennifer VandoorenRega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Nele BerghmansRega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Chris DillenRega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Ilse Van AelstRega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Isabelle RonsseRega Institute for Medical Research, University of Leuven, Leuven, Belgium.
Liron Limor IsraelDepartment of Chemistry and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel.
Ina RosenbergerInstitut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany.
Jörg KreuterInstitut für Pharmazeutische Technologie, Johann Wolfgang Goethe-Universität, Frankfurt, Germany.
Jean-Paul LelloucheDepartment of Chemistry and Institute of Nanotechnology and Advanced Materials, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel.
Shulamit MichaeliThe Mina and Everard Goodman Faculty of Life Sciences and Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat Gan, Tel Aviv, Israel.
Erica LocatelliDepartment of Industrial Chemistry Toso Montanari, University of Bologna, Bologna, Italy.
Mauro Comes FranchiniDepartment of Industrial Chemistry Toso Montanari, University of Bologna, Bologna, Italy.
Miren K AiertzaNew Materials Department, Fundación CIDETEC, San Sebastián, Spain.
Laura Sánchez-AbellaNew Materials Department, Fundación CIDETEC, San Sebastián, Spain.
Iraida LoinazNew Materials Department, Fundación CIDETEC, San Sebastián, Spain.
Dylan R EdwardsSchool of Biological Sciences, University of East Anglia, Norwich, UK.
Louis ShenkmanTel Aviv University, Ramat Aviv, Tel Aviv, Israel.
Ghislain OpdenakkerRega Institute for Medical Research, University of Leuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The need for test systems for nanoparticle biocompatibility, toxicity, and inflammatory or adaptive immunological responses is paramount. Nanoparticles should be free of microbiological and chemical contaminants, and devoid of toxicity. Nevertheless, in the absence of contamination, these particles may still induce undesired immunological effects in vivo, such as enhanced autoimmunity, hypersensitivity reactions, and fibrosis. Here we show that artificial particles of specific sizes affect immune cell recruitment as tested in a dermal air pouch model in mice. In addition, we demonstrate that the composition of nanoparticles may influence immune cell recruitment in vivo. Aside from biophysical characterizations in terms of hydrodynamic diameter, zeta potential, concentration, and atomic concentration of metals, we show that - after first-line in vitro assays - characterization of cellular and molecular effects by dermal air pouch analysis is straightforward and should be included in the quality control of nanoparticles. We demonstrate this for innate immunological effects such as neutrophil recruitment and the production of immune-modulating matrix metalloproteases such as MMP-9; we propose the use of air pouch leukocytosis analysis as a future standard assay.

Indexed as

AirAnimalsBiological AssayLeukocytosisMaterials TestingMiceNanoparticlesParticle SizePolystyrenesToxicity TestsPolystyrenesair pouchbiocompatibilityimmunologynanoparticlestoxicity

Identifiers

PMID24379662
PMCPMC3867323

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.